| D00076 |
Noradrenaline (JP18); Norepinephrine (INN); Nor adrenalin (TN) |
(P) unclassified |
| D00095 |
Epinephrine (USP/INN); Adrenaline (JP18); Adrenalin (TN); Auvi-q (TN); Epipen (TN) |
(P) unclassified |
| D00136 |
Haloperidol (JP18/USP/INN); Haldol (TN) |
(P) CYP inhibition: CYP2D6 |
| D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) unclassified |
| D00295 |
Cimetidine (JP18/USP/INN); Tagamet (TN) |
(P) unclassified |
| D00311 |
Estazolam (JP18/USP/INN); ProSom (TN) |
(P) unclassified |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) unclassified |
| D00415 |
Zolmitriptan (JAN/USP/INN); Zomig (TN) |
(P) Enzyme: CYP1A2 |
| D00426 |
Risperidone (JP18/USP/INN); Risperdal (TN) |
(P) CYP inhibition: CYP2D6 |
| D00451 |
Sumatriptan (JAN/USP/INN); Imigran (TN); Imitrex (TN) |
(P) unclassified |
| D00603 |
Timolol maleate (JP18/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) CYP inhibition: CYP2D6 |
| D00605 |
Guanabenz acetate (JP18/USP); Wytensin (TN) |
(P) unclassified |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) CYP inhibition: CYP2D6 |
| D00674 |
Naratriptan hydrochloride (JAN/USP); Amerge (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP2D6 |
| D00675 |
Rizatriptan benzoate (JAN/USP); Maxalt (TN) |
(P) unclassified |
| D00676 |
Sumatriptan succinate (JAN/USP); Alsuma (TN); Imitrex (TN); Sumave dosepro (TN); Zecutity (TN) |
(P) unclassified |
| D00677 |
Granisetron hydrochloride (JAN/USP); Kytril (TN) |
(P) unclassified |
| D00678 |
Ondansetron hydrochloride hydrate (JAN/USP); Ondansetron hydrochloride; Zofran (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP2D6 |
| D00754 |
Thalidomide (JAN/USP/INN); Thalomid (TN); Thaled (TN) |
(P) unclassified |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(CI) CYP inhibition: CYP2D6 |
| D00801 |
Lithium carbonate (JP18/USP); Eskalith (TN); Lithobid (TN) |
(P) unclassified |
| D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) Target: SLC6A2 SLC6A4 / CYP inhibition: CYP2D6 |
| D00811 |
Clomipramine hydrochloride (JP18/USP); Anafranil (TN) |
(P) Target: SLC6A2 SLC6A4 / CYP inhibition: CYP2D6 |
| D00815 |
Imipramine hydrochloride (JP18/USP); Tofranil (TN) |
(P) Target: SLC6A2 SLC6A4 / CYP inhibition: CYP2D6 |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) Target: SLC6A4 / CYP inhibition: CYP2D6 |
| D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) Target: SLC6A2 SLC6A4 / CYP inhibition: CYP2D6 |
| D00848 |
Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP18); Benylin DM (TN) |
(P) CYP inhibition: CYP2D6 |
| D00947 |
Linezolid (JAN/USAN/INN); Zyvox (TN) |
(P) unclassified |
| D01164 |
Aripiprazole (JAN/USP/INN); Abilify (TN) |
(P) CYP inhibition: CYP2D6 |
| D01179 |
Duloxetine hydrochloride (JAN/USP); Cymbalta (TN); Yentreve (TN) |
(P) Enzyme: CYP1A2 / Target: SLC6A2 SLC6A4 |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01383 |
Meperidine hydrochloride (USP); Pethidine hydrochloride (JP18); Demerol (TN) |
(P) unclassified |
| D01399 |
Fentanyl citrate (JP18/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) unclassified |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) CYP inhibition: CYP2D6 |
| D01973 |
Eletriptan hydrobromide (JAN/USAN); Relpax (TN) |
(P) unclassified |
| D01992 |
Tandospirone citrate (JAN/USAN); SM 3997; Sediel (TN) |
(P) unclassified |
| D02106 |
Arsenic trioxide (JP18/USAN); Trisenox (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02562 |
Rasagiline mesylate (USAN); Rasagiline mesilate (JAN); Azilect (TN) |
(CI) Enzyme: CYP1A2 |
| D02574 |
Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) |
(P) Target: SLC6A2 / CYP inhibition: CYP2D6 |
| D03855 |
Pethidine hydrochloride and levallorphan tartrate; Pethilorfan (TN) |
(P) unclassified |
| D04052 |
Epinephrine and lidocaine hydrochloride; Adrenaline and lidocaine hydrochloride; Xylocaine (TN) |
(P) Enzyme: CYP1A2 |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) Enzyme: CYP1A2 / Target: SLC6A4 / CYP inhibition: CYP2D6 |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) CYP inhibition: CYP2D6 |
| D04747 |
Lisdexamfetamine dimesylate (USAN); Lisdexamfetamine mesilate (JAN); Vyvanse (TN); Elvanse (TN) |
(P) Target: SLC6A2 |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN) |
(P) unclassified |
| D07082 |
Dabigatran etexilate mesylate (USAN); Dabigatran etexilate methanesulfonate (JAN); Dabigatran etexilate mesilate; Pradaxa (TN) |
(P) unclassified |
| D07086 |
Rivaroxaban (JAN/USAN/INN); Xarelto (TN) |
(P) unclassified |
| D07505 |
Latanoprost and timolol maleate; Xalacom (TN) |
(P) unclassified |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP18); Cosopt (TN) |
(P) CYP inhibition: CYP2D6 |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP2D6 |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) CYP inhibition: CYP2D6 |
| D09535 |
Mirabegron (JAN/USAN/INN); Myrbetriq (TN) |
(P) unclassified |
| D09546 |
Edoxaban tosilate hydrate (JAN); Edoxaban tosylate monohydrate; Lixiana (TN); Savaysa (TN) |
(P) unclassified |
| D09701 |
Abiraterone acetate (JAN/USP); Zytiga (TN) |
(P) unclassified |
| D09815 |
Travoprost and timolol maleate; Duotrav (TN) |
(P) unclassified |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) CYP inhibition: CYP2D6 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP inhibition: CYP1A2 |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) unclassified |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) Target: SLC6A4 / CYP inhibition: CYP2D6 |
| D10191 |
Safinamide mesylate (USAN); Safinamide mesilate (JAN); Safinamide methanesulfonate; Xadago (TN); Equfina (TN) |
(CI) unclassified |
| D10199 |
Tapentadol hydrochloride (JAN); Nucynta (TN) |
(P) Target: SLC6A2 |
| D10298 |
Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) |
(P) unclassified |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) CYP inhibition: CYP2D6 |
| D10424 |
Lasmiditan succinate (JAN/USAN); lasmiditan hemisuccinate; Reyvow (TN) |
(P) unclassified |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) CYP inhibition: CYP2D6 |
| D10514 |
Dacomitinib (USAN); Dacomitinib hydrate (JAN); Vizimpro (TN) |
(P) unclassified |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) CYP inhibition: CYP2D6 |
| D10537 |
Methylthioninium chloride hydrate (JAN); Methylene blue (TN) |
(P) CYP inhibition: CYP1A2 |
| D10569 |
Tafluprost and timolol maleate; Tapcom (TN) |
(P) unclassified |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) unclassified |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) unclassified |
| D11027 |
Ropeginterferon alfa-2b (INN); Ropeginterferon alfa-2b (genetical recombination) (JAN); Ropeginterferon alfa-2b-njft; Besremi (TN) |
(P) unclassified |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) CYP inhibition: CYP2D6 |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) unclassified |
| D11708 |
Givosiran sodium (JAN); Givlaari (TN) |
(P) unclassified |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) CYP inhibition: CYP1A2 |
